SYNSHARK LLC
Leland, NC · Founded 2013 · CIK 0001699383 · Biotech
pharmaceutical-grade squalene produced from engineered tobacco plants for use as a vaccine adjuvant
- Grants
- $1.0M
- 3 awards
- Sector median: 1
- Raised
- $213K
- 1 Form D · Mar 2017
- 115 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $213,000 | |
| Federal grant | Department of Agriculture · Development Of High Squalene Tobacco | $100,000 | |
| Federal grant | Department of Agriculture · Development Of High Squalene Tobacco | $650,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Tobacco-based Sustainable Squalene for Novel Vaccine Adjuvant Emulsions | $257,003 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1898 | Direct Biologics, LLC | — | $12M |
| 1899 | Inograft Biotherapeutics | — | — |
| 1900 | ImmunoPrecise Antibodies Ltd. | — | $2.5M |
| 1901 | SYNSHARK LLC | — | $213K |
| 1902 | Blank! The Musical LLC | — | $550K |
| 1903 | SEQLL, LLC | — | $2.5M |
| 1904 | NANOMEDTRIX LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Yuan DaiDirector · Executive Officer
- Jason OrnsteinDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.